![](https://investorshub.advfn.com/uicon/710573.png?cb=1589984294)
Wednesday, July 22, 2020 4:36:54 PM
$BNGO | +35% Upside for #BionanoGenomics
Maxim Group analyst Jason McCarthy assigned a Buy rating to BioNano Genomics ( BNGO ) yesterday and set a price target of $2.00. The company’s shares closed last Tuesday at $0.83, close to its 52-week low of $0.25.
BioNano Genomics , Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
![](http://investorshub.advfn.com/uimage/uploads/2020/7/22/mvk[iBNGO.png)
Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:
#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/
#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent BNGO News
- Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research • GlobeNewswire Inc. • 06/20/2024 12:00:00 PM
- Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/10/2024 09:12:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:49:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:48:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:43:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:42:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:40:14 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 06/05/2024 06:59:46 PM
- Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow • GlobeNewswire Inc. • 05/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 12:15:32 PM
- Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/08/2024 09:27:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:09:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:02:28 PM
- Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress • GlobeNewswire Inc. • 05/08/2024 08:01:00 PM
- Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
- Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/04/2024 05:44:35 PM
- Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM